Atropine Sulfate Injection, Solution
Product Images NDC 51662-1208

10 FDA label images from Hf Acquisition Co., Llc, Dba Health First · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Atropine Sulfate (NDC 51662-1208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co., Llc, Dba Health First, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dosage And Administration (Dosage And Administration)

Dosage And Administration (Dosage And Administration)
A table listing adult dose information for Atropine Sulfate injection. It includes uses such as antisialagogue or antivagal, organophosphorus or muscarinic mushroom poisoning, and bradyasystolic cardiac arrest, with corresponding dose ranges and repeat intervals.*
FDA Label Image

Structure (Image)

Structure (Image)
Chemical structure of atropine sulfate dihydrate, showing the molecular arrangement of atropine combined with sulfate and water molecules.*
FDA Label Image
FDA Label Image

Serialized Label (51662 1208 1 Atropine Sulfate 0.5 5 mL Serialized Label On Box)

Serialized Label (51662 1208 1 Atropine Sulfate 0.5 5 mL Serialized Label On Box)
Packaging label for Atropine Sulfate Injection, USP, 0.1 mg/3 mL solution, distributed by HF Acquisition Co., LLC. The label advises usage instructions about needle handling and storage conditions at 20°C to 25°C with permitted excursions between 15°C and 30°C. It includes barcodes and manufacturer information for this prescription intravenous injection.*
FDA Label Image

5 mL Syringe (1000090 0409 4910 11 Atropine 5ml Syringe)

5 mL Syringe (1000090 0409 4910 11 Atropine 5ml Syringe)
Label for Atropine Sulfate Injection, USP 0.5 mg/5 mL (0.1 mg/mL) in a 5 mL single-dose syringe. The product is for intravenous use and is labeled for prescription only. Distributed by Hospira, Inc., Lake Forest, IL, USA. The NDC number 0409-4910-11 is shown.*
FDA Label Image

5 mL Box (1000090 0409 4910 11 Atropine 5ml Box)

5 mL Box (1000090 0409 4910 11 Atropine 5ml Box)
Atropine Sulfate Injection USP 0.5 mg/5 mL (0.1 mg/mL) glass syringe label by HF Acquisition Co., LLC, DBA Health First. The label indicates a 5 mL single-dose syringe with a male luer lock adapter and 20-gauge protected needle for intravenous use. Instructions for aseptic use and vial handling are illustrated. The label shows storage conditions and barcode details.*
FDA Label Image

Syringe Packaging (1208 2 Syringe Packaging)

Syringe Packaging (1208 2 Syringe Packaging)
Packaging label for Atropine Sulfate Injection, USP 0.5 mg/5 mL (0.1 mg/mL) intravenous solution in a 5 mL single-dose glass syringe. Label includes instructions for use, cautions, and identification of the product with a male luer lock adapter and 20-gauge protected needle. Distributed by Hospira, Inc., with NDC 0409-4910-11, the label also shows lot and expiration date placeholders and safety warnings about liquid handling and aseptic use.*
FDA Label Image

Pouch Labeling (1208 2 Pouch)

Pouch Labeling (1208 2 Pouch)
Label for Atropine Sulfate Injection, USP, 0.5 mg/5 mL (0.1 mg/mL) solution in a 5 mL syringe. The label includes the National Drug Code (NDC) 51662-1208, lot number, and expiration date. It states the medication is for intravenous use, provides component details, storage instructions, and manufacturer information: HF Acquisition Co., LLC, Mukilteo, WA. The label also notes RX only and directs to see the manufacturer's package insert.*
FDA Label Image

Case (1208 3 Case)

Case (1208 3 Case)
ATROPINE SULFATE INJECTION, USP 0.5 mg/5 mL (0.1 mg/mL) vial label for a 5 mL syringe, case of 10. The label includes NDC 51662-1208-3, lot number, expiration date, manufacturer details showing HF Acquisition Co., LLC in Mukilteo, WA, and usage instructions for intravenous administration.*
FDA Label Image

Rfid Label (51662 1208 3 Rfid)

Rfid Label (51662 1208 3 Rfid)
Label of ATROPINE SULFATE injection solution, 0.1 mg/mL, for intravenous use. The label includes barcodes, text codes, and distributor information indicating it is distributed by HF Acquisitions Co., LLC, Mukilteo, WA 98275. The label instructs to see the manufacturer's insert for more information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.